Maryland Momentum Fund and VTC Innovation Fund have both contributed to a series A round for Veralox Therapeutics, which is focusing on diseases with unmet needs.

Bitwise Asset Management completed a $70m round backed by Coinbase at a $500m-plus valuation, while luxury goods wholesaler Joor raised $46m to take its overall funding to $81m.

UPMC Enterprises has contributed to a series B round for Sempre Health, which is building a platform to make drugs more affordable for patients.

Gene therapy startup VectorY has raised more than $37m in an Eli Lilly-backed seed round while AR helmet developer XYZ Reality pulled in over $28m.

Transcarent has raised $58m from Bayer and Merck, while Nvidia has bought DeepMap, one of its portfolio companies also backed by Bosch.

Blockchain game developer Mythical Games pulled in $75m while enterprise software developer Morning Consult reached a unicorn valuation in an Advance Venture Partners-led round.

Based on research at Ecole Normale Supérieure and CNRS, C12 is commercialising quantum processors.

Helsinki spinout Aiforia has raised an initial $15.4m in series B funding, bringing it halfway to the round’s target.

KAUST has returned for a $10m funding round for Red Sea Farms, having previously contributed to a $1.9m round two years ago.

Bridge Bank and Multiplier Capital have co-led a $14m funding round for Sharpen Technologies, whose shareholders already include the IU Philanthropic Venture Fund.